Works by Demirkan, Fatih


Results: 47
    1

    Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?

    Published in:
    Molecular Cytogenetics (17558166), 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13039-020-00522-1
    By:
    • Durak Aras, Beyhan;
    • Isik, Sevgi;
    • Uskudar Teke, Hava;
    • Aslan, Abdulvahap;
    • Yavasoglu, Filiz;
    • Gulbas, Zafer;
    • Demirkan, Fatih;
    • Ozen, Hulya;
    • Cilingir, Oguz;
    • Inci, Nur Sena;
    • Gunden, Gulcin;
    • Bulduk, Tuba;
    • Erzurumluoglu Gokalp, Ebru;
    • Kocagil, Sinem;
    • Artan, Sevilhan;
    • Akay, Olga Meltem
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Bortezomib-Induced Skin Lesion.

    Published in:
    Acta Haematologica, 2006, v. 116, n. 3, p. 226, doi. 10.1159/000094689
    By:
    • Ozcan, Mehmet Ali;
    • Alacacioglu, Inci;
    • Piskin, Ozden;
    • Lebe, Banu;
    • Turgut, Nurhilal;
    • Ceneli, Selda;
    • Demirkan, Fatih;
    • Ozsan, Guner Hayri;
    • Undar, Bulent
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis.

    Published in:
    Eurasian Journal of Medicine & Oncology, 2023, v. 7, n. 1, p. 49, doi. 10.14744/ejmo.2023.64688
    By:
    • Guven, Serkan;
    • Yavuz, Boran;
    • Yucel, Elcin Erdogan;
    • Karatas, Aylin Fatma;
    • Ozsan, Guner Hayri;
    • Demirkan, Fatih;
    • Undar, Bulent;
    • Ozcan, Mehmet Ali;
    • Kiper, Hatice Demet;
    • Cetintepe, Tugba;
    • Gocer, Mesut;
    • Kurtoglu, Erdal;
    • Aydin, Berrin Balik;
    • Sevindik, Omur Gokmen;
    • Kaya, Sureyya Yigit;
    • Alacacioglu, Inci
    Publication type:
    Article
    22
    23
    24
    25

    Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.

    Published in:
    Pharmaceutical Research, 2019, v. 36, n. 7, p. N.PAG, doi. 10.1007/s11095-019-2605-8
    By:
    • Lavezzi, Silvia Maria;
    • de Jong, Jan;
    • Neyens, Martine;
    • Cramer, Paula;
    • Demirkan, Fatih;
    • Fraser, Graeme;
    • Bartlett, Nancy;
    • Dilhuydy, Marie-Sarah;
    • Loscertales, Javier;
    • Avigdor, Abraham;
    • Rule, Simon;
    • Samoilova, Olga;
    • Goy, Andre;
    • Ganguly, Siddhartha;
    • Salman, Mariya;
    • Howes, Angela;
    • Mahler, Michelle;
    • De Nicolao, Giuseppe;
    • Poggesi, Italo
    Publication type:
    Article
    26
    27
    28

    Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

    Published in:
    Clinical Transplantation, 2018, v. 32, n. 9, p. 1, doi. 10.1111/ctr.13359
    By:
    • Solmaz Medeni, Serife;
    • Acar, Celal;
    • Olgun, Aybuke;
    • Acar, Alev;
    • Seyhanlı, Ahmet;
    • Taskıran, Emin;
    • Sevindik, Omur Gokmen;
    • Alacacıoglu, Inci;
    • Piskin, Ozden;
    • Ozcan, Mehmet Ali;
    • Demirkan, Fatih;
    • Undar, Bulent;
    • Ozsan, Guner Hayri
    Publication type:
    Article
    29
    30
    31

    The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia.

    Published in:
    UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2012, v. 22, p. 8, doi. 10.4999/uhod.12004
    By:
    • AKSU, Salih;
    • SAHIN, Fahri;
    • UZ, Burak;
    • YAVUZ, Selim A.;
    • ATAY, Hilmi;
    • KELKITLI, Engin;
    • TURGUT, Mehmet;
    • PEHLIVAN, Mustafa;
    • AKAY, Meltem O.;
    • GURKAN, Emel;
    • DEMIR, Muzaffer;
    • KAHRAMAN, Selda;
    • DEMIRKAN, Fatih;
    • PAYDAS, Semra;
    • SAYDAM, Güray;
    • HAZNEDAROGLU, Ibrahim C.
    Publication type:
    Article
    32
    33
    34
    35

    Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1375, doi. 10.1080/10428194.2021.2020779
    By:
    • Burger, Jan A.;
    • Robak, Tadeusz;
    • Demirkan, Fatih;
    • Bairey, Osnat;
    • Moreno, Carol;
    • Simpson, David;
    • Munir, Talha;
    • Stevens, Don A.;
    • Dai, Sandra;
    • Cheung, Leo W. K.;
    • Kwei, Kevin;
    • Lal, Indu;
    • Hsu, Emily;
    • Kipps, Thomas J.;
    • Tedeschi, Alessandra
    Publication type:
    Article
    36

    Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 13, p. 3188, doi. 10.1080/10428194.2020.1795159
    By:
    • Fraser, Graeme A.M.;
    • Chanan-Khan, Asher;
    • Demirkan, Fatih;
    • Santucci Silva, Rodrigo;
    • Grosicki, Sebastian;
    • Janssens, Ann;
    • Mayer, Jiri;
    • Bartlett, Nancy L.;
    • Dilhuydy, Marie-Sarah;
    • Loscertales, Javier;
    • Avigdor, Abraham;
    • Rule, Simon;
    • Samoilova, Olga;
    • Pavlovsky, Miguel A.;
    • Goy, Andre;
    • Mato, Anthony;
    • Hallek, Michael;
    • Salman, Mariya;
    • Tamegnon, Monelle;
    • Sun, Steven
    Publication type:
    Article
    37
    38
    39
    40

    Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy.

    Published in:
    Advances in Therapy, 2021, v. 38, n. 2, p. 1328, doi. 10.1007/s12325-020-01601-w
    By:
    • Chari, Ajai;
    • Munder, Markus;
    • Weisel, Katja;
    • Jenner, Matthew;
    • Bygrave, Ceri;
    • Petrucci, Maria Teresa;
    • Boccadoro, Mario;
    • Cavo, Michele;
    • van de Donk, Niels W. C. J.;
    • Turgut, Mehmet;
    • Demirkan, Fatih;
    • Karadogan, Ihsan;
    • Libby, Edward;
    • Kleiman, Robert;
    • Kuppens, Steven;
    • Bandekar, Rajesh;
    • Neff, Tobias;
    • Heuck, Christoph;
    • Qi, Ming;
    • Clemens, Pamela L.
    Publication type:
    Article
    41

    Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG).

    Published in:
    Turkish Journal of Hematology, 2022, v. 39, n. 3, p. 170, doi. 10.4274/tjh.galenos.2022.2022.0052
    By:
    • Kayıkçı, Ömür;
    • Mehtap, Özgür;
    • Sarı, İsmail;
    • Demirkan, Fatih;
    • Beyan, Cengiz;
    • Çetin, Güven;
    • Vural, Filiz;
    • Yılmaz, Mehmet;
    • Öztürk, Erman;
    • Akpınar, Seval;
    • Eser, Bülent;
    • Gündüz, Mehmet;
    • Büyükaşık, Yahya;
    • Payzın, Bahriye;
    • Yıldırım, Rahşan;
    • Doğu, Mehmet Hilmi;
    • Özkan, Atilla;
    • Kelkitli, Engin;
    • Tekgündüz, Emre
    Publication type:
    Article
    42
    43

    Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study.

    Published in:
    Turkish Journal of Hematology, 2019, v. 36, n. 3, p. 169, doi. 10.4274/tjh.galenos.2019.2019.0008
    By:
    • Çiftçiler, Rafiye;
    • Sevindik, Ömür Gökmen;
    • Tekgündüz, Ali İrfan Emre;
    • Erkurt, Mehmet Ali;
    • Vural, Filiz;
    • Turgut, Burhan;
    • Kaynar, Leylagül;
    • Payzın, Bahriye;
    • Doğu, Mehmet Hilmi;
    • Karakuş, Volkan;
    • Altuntaş, Fevzi;
    • Büyükaşık, Yahya;
    • Demirkan, Fatih
    Publication type:
    Article
    44
    45

    Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?

    Published in:
    Turkish Journal of Hematology, 2018, v. 35, n. 4, p. 271, doi. 10.4274/tjh.2018.0071
    By:
    • Medeni, Şerife Solmaz;
    • Türkyılmaz, Doğuş;
    • Acar, Celal;
    • Sevindik, Ömür Gökmen;
    • Yüksel, Faize;
    • Pişkin, Özden;
    • Özcan, Mehmet Ali;
    • Demirkan, Fatih;
    • Ündar, Bülent;
    • Alacacıoğlu, İnci;
    • Özsan, Güner Hayri
    Publication type:
    Article
    46
    47

    Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.

    Published in:
    Turkish Journal of Hematology, 2013, v. 30, n. 4, p. 351, doi. 10.4274/tjh.2013.0151
    By:
    • Şahin, Fahri;
    • Saydam, Güray;
    • Cömert, Melda;
    • Uz, Burak;
    • Yavuz, Akif Selim;
    • Turan, Esra;
    • Yönal, İpek;
    • Atay, Hilmi;
    • Kekikli, Engin;
    • Turgut, Mehmet;
    • Pehlivan, Mustafa;
    • Akay, Meltem Olga;
    • Gürkan, Emel;
    • Paydaş, Semra;
    • Kahraman, Selda;
    • Demirkan, Fatih;
    • Klrklzlar, Onur;
    • Akpınar, Seval;
    • Pamuk, Gülsüm Emel;
    • Demir, Muzaffer
    Publication type:
    Article